中华糖尿病杂志
中華糖尿病雜誌
중화당뇨병잡지
Chinese Journal of Diabetes Mellitus
2015年
9期
571-575
,共5页
魏琼%陈济安%孙玉香%王少华%李玲%孙子林
魏瓊%陳濟安%孫玉香%王少華%李玲%孫子林
위경%진제안%손옥향%왕소화%리령%손자림
肥胖%棕色脂肪%胰高血糖素样肽1受体激动剂
肥胖%棕色脂肪%胰高血糖素樣肽1受體激動劑
비반%종색지방%이고혈당소양태1수체격동제
Obesity%Brown fat%Glucagon-like peptide-1 receptor agonist
目的:观察胰高血糖素样肽1(GLP-1)受体激动剂exendin-4干预对高脂饮食喂养的C57BL/6J小鼠棕色脂肪脂代谢的影响。方法将30只健康雄性6周龄C57BL/6J小鼠采用随机数字法分为正常组、高脂组、exendin-4干预组,每组10只。高脂组给予高脂饲料喂养、exendin-4干预组给予高脂饲料喂养联合exendin-4皮下注射。16周后,测定各组体重、体脂含量、游离脂肪酸、瘦素、甘油三酯水平,同时利用实时定量PCR和Western blotting法检测各组小鼠肩胛棕色脂肪葡萄糖转运体4(GLUT-4)、过氧化物酶体增殖剂激活受体γ2(PPAR-γ2)、脂滴包被蛋白(perilipin)和解偶联蛋白1(UCP-1) mRNA及蛋白表达。多组间数据比较采用单因素方差分析,两组间比较采用t检验。结果与正常组相比,高脂组小鼠体重、体脂成分、游离脂肪酸、瘦素、甘油三酯的水平明显升高(t=7.34、6.11、8.33、10.51、4.19,均P<0.05);且高脂组肩胛棕色脂肪GLUT-4、PPAR-γ2、perilipin和UCP-1的基因和蛋白表达均显著下降(t=7.15~34.79,均P<0.05)。与高脂组相比,exendin-4干预组小鼠体重、体脂成分、游离脂肪酸、瘦素、甘油三酯均较高脂组显著降低(t=5.63、4.04、8.85、6.06、3.07,均P<0.05),同时exendin-4干预组小鼠肩胛棕色脂肪GLUT-4、PPAR-γ2、perilipin和UCP-1基因和蛋白表达均较高脂组显著升高(t=5.38~21.69,均P<0.05)。结论 GLP-1受体激动剂可能通过调控棕色脂肪脂代谢而影响体重。
目的:觀察胰高血糖素樣肽1(GLP-1)受體激動劑exendin-4榦預對高脂飲食餵養的C57BL/6J小鼠棕色脂肪脂代謝的影響。方法將30隻健康雄性6週齡C57BL/6J小鼠採用隨機數字法分為正常組、高脂組、exendin-4榦預組,每組10隻。高脂組給予高脂飼料餵養、exendin-4榦預組給予高脂飼料餵養聯閤exendin-4皮下註射。16週後,測定各組體重、體脂含量、遊離脂肪痠、瘦素、甘油三酯水平,同時利用實時定量PCR和Western blotting法檢測各組小鼠肩胛棕色脂肪葡萄糖轉運體4(GLUT-4)、過氧化物酶體增殖劑激活受體γ2(PPAR-γ2)、脂滴包被蛋白(perilipin)和解偶聯蛋白1(UCP-1) mRNA及蛋白錶達。多組間數據比較採用單因素方差分析,兩組間比較採用t檢驗。結果與正常組相比,高脂組小鼠體重、體脂成分、遊離脂肪痠、瘦素、甘油三酯的水平明顯升高(t=7.34、6.11、8.33、10.51、4.19,均P<0.05);且高脂組肩胛棕色脂肪GLUT-4、PPAR-γ2、perilipin和UCP-1的基因和蛋白錶達均顯著下降(t=7.15~34.79,均P<0.05)。與高脂組相比,exendin-4榦預組小鼠體重、體脂成分、遊離脂肪痠、瘦素、甘油三酯均較高脂組顯著降低(t=5.63、4.04、8.85、6.06、3.07,均P<0.05),同時exendin-4榦預組小鼠肩胛棕色脂肪GLUT-4、PPAR-γ2、perilipin和UCP-1基因和蛋白錶達均較高脂組顯著升高(t=5.38~21.69,均P<0.05)。結論 GLP-1受體激動劑可能通過調控棕色脂肪脂代謝而影響體重。
목적:관찰이고혈당소양태1(GLP-1)수체격동제exendin-4간예대고지음식위양적C57BL/6J소서종색지방지대사적영향。방법장30지건강웅성6주령C57BL/6J소서채용수궤수자법분위정상조、고지조、exendin-4간예조,매조10지。고지조급여고지사료위양、exendin-4간예조급여고지사료위양연합exendin-4피하주사。16주후,측정각조체중、체지함량、유리지방산、수소、감유삼지수평,동시이용실시정량PCR화Western blotting법검측각조소서견갑종색지방포도당전운체4(GLUT-4)、과양화물매체증식제격활수체γ2(PPAR-γ2)、지적포피단백(perilipin)화해우련단백1(UCP-1) mRNA급단백표체。다조간수거비교채용단인소방차분석,량조간비교채용t검험。결과여정상조상비,고지조소서체중、체지성분、유리지방산、수소、감유삼지적수평명현승고(t=7.34、6.11、8.33、10.51、4.19,균P<0.05);차고지조견갑종색지방GLUT-4、PPAR-γ2、perilipin화UCP-1적기인화단백표체균현저하강(t=7.15~34.79,균P<0.05)。여고지조상비,exendin-4간예조소서체중、체지성분、유리지방산、수소、감유삼지균교고지조현저강저(t=5.63、4.04、8.85、6.06、3.07,균P<0.05),동시exendin-4간예조소서견갑종색지방GLUT-4、PPAR-γ2、perilipin화UCP-1기인화단백표체균교고지조현저승고(t=5.38~21.69,균P<0.05)。결론 GLP-1수체격동제가능통과조공종색지방지대사이영향체중。
Objective To investigate the role of exendin-4 treatment on fat metabolism of brown adipose tissue in C57BL/6J mice induced with high-fat diet. Methods Thirty six-week-old C57BL/6J mice were randomly divided into 3 groups(10 mice in each group):control group, high-fat diet (HFD) group, and HFD group treated with exendin-4. After 16 weeks, the body weight, body fat composition, free fatty acids, leptin, triglycerides level of each group were measured. The mRNA and protein expression of glucose transporter type 4 (GLUT-4), peroxisome proliferative activated receptor γ2(PPAR-γ2), perilipin and uncoupling protein 1(UCP-1) in the scapular brown adipose tissue were detected with real-time quantitative polymerase chain reaction(PCR) and Western blotting methods. One-way ANOVA was used when data were compared among multiple groups and t analysis was applied for comparison between two groups. Results Compared with those in control group, the body weight, body fat composition, free fatty acids, leptin and triglyceride levels increased significantly in the HFD group (t=7.34, 6.11, 8.33, 10.51, 4.19, all P<0.05);the mRNA and protein expression of GLUT-4, PPAR-γ2, perilipin and UCP-1 in the scapular brown adipose tissue in HFD group decreased significantly when compared with those in control group (t=7.15-34.79, all P<0.05). Compared with those in the HFD group, the body weight, body fat composition, free fatty acids, leptin and triglyceride levels decreased significantly in the exendin-4-treating group(t=5.63, 4.04, 8.85, 6.06, 3.07, all P<0.05), while the mRNA and protein expression of GLUT-4, PPAR-γ2, perilipin and UCP-1 increased significantly in the scapular brown adipose tissue in the exendin-4-treating group(t=5.38-21.69, all P<0.05). Conclusion GLP-1 receptor agonist may reduce body weight via regulating lipid metabolism in brown fat.